PMC:7441788 / 1191-1822
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T13 | 89-97 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T14 | 184-192 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T15 | 299-307 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T16 | 382-390 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T17 | 537-545 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T18 | 557-604 | Disease | denotes | severe acute respiratory syndrome coronavirus 2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T19 | 557-590 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T20 | 606-614 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T6 | 25-26 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T14 | 27-36 | Chemical | denotes | macrolide | http://purl.obolibrary.org/obo/CHEBI_25106 |
| T15 | 161-163 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T16 | 275-277 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T17 | 357-368 | Chemical | denotes | application | http://purl.obolibrary.org/obo/CHEBI_33232 |
| T18 | 372-374 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-sample-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T11 | 27-36 | Chemical | denotes | macrolide | http://purl.obolibrary.org/obo/CHEBI_25106 |
| T12 | 161-163 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T13 | 275-277 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T14 | 372-374 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-sample-PD-NCBITaxon
| Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
|---|---|---|---|---|---|
| T11 | 89-97 | Species | denotes | COVID-19 | NCBItxid:2697049 |
| T12 | 184-192 | Species | denotes | COVID-19 | NCBItxid:2697049 |
| T13 | 299-307 | Species | denotes | COVID-19 | NCBItxid:2697049 |
| T14 | 382-390 | Species | denotes | COVID-19 | NCBItxid:2697049 |
| T15 | 537-545 | Species | denotes | COVID-19 | NCBItxid:2697049 |
| T16 | 557-604 | Species | denotes | severe acute respiratory syndrome coronavirus 2 | NCBItxid:2697049 |
| T17 | 606-616 | Species | denotes | SARS-CoV-2 | NCBItxid:2697049 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T15 | 99-202 | Sentence | denotes | Adverse effects, including prolonged QT interval after taking CQ/HCQ, may develop in COVID-19 patients. |
| T16 | 203-494 | Sentence | denotes | Therefore, current data are not sufficient enough to support the use of CQ/HCQ as therapies for COVID-19 and increasing caution should be taken about the application of CQ/HCQ in COVID-19 before conclusive findings are obtained by well-designed, multi-center, randomized, controlled studies. |
| T17 | 496-498 | Sentence | denotes | 1. |
| T18 | 500-512 | Sentence | denotes | Introduction |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 105 | 557-604 | Species | denotes | severe acute respiratory syndrome coronavirus 2 | Tax:2697049 |
| 106 | 606-616 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 120 | 537-545 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 46 | 75-83 | Species | denotes | patients | Tax:9606 |
| 47 | 193-201 | Species | denotes | patients | Tax:9606 |
| 56 | 27-36 | Chemical | denotes | macrolide | MESH:D018942 |
| 57 | 161-163 | Chemical | denotes | CQ | MESH:D002738 |
| 58 | 164-167 | Chemical | denotes | HCQ | MESH:D006886 |
| 59 | 275-277 | Chemical | denotes | CQ | MESH:D002738 |
| 60 | 278-281 | Chemical | denotes | HCQ | MESH:D006886 |
| 61 | 372-374 | Chemical | denotes | CQ | MESH:D002738 |
| 62 | 375-378 | Chemical | denotes | HCQ | MESH:D006886 |
| 70 | 89-97 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 71 | 184-192 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 72 | 299-307 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 73 | 382-390 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sample-PD-IDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T5 | 525-532 | http://purl.obolibrary.org/obo/OGMS_0000031 | denotes | disease |
LitCovid-sample-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T11 | 89-97 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T12 | 184-192 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T13 | 299-307 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T14 | 382-390 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T15 | 513-535 | Disease | denotes | Coronavirus disease-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T16 | 537-545 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T17 | 557-604 | Disease | denotes | severe acute respiratory syndrome coronavirus 2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T18 | 606-616 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sample-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 126-147 | Phenotype | denotes | prolonged QT interval | http://purl.obolibrary.org/obo/HP_0001657 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 46 | 75-83 | Species | denotes | patients | Tax:9606 |
| 47 | 193-201 | Species | denotes | patients | Tax:9606 |
| 56 | 27-36 | Chemical | denotes | macrolide | MESH:D018942 |
| 57 | 161-163 | Chemical | denotes | CQ | MESH:D002738 |
| 58 | 164-167 | Chemical | denotes | HCQ | MESH:D006886 |
| 59 | 275-277 | Chemical | denotes | CQ | MESH:D002738 |
| 60 | 278-281 | Chemical | denotes | HCQ | MESH:D006886 |
| 61 | 372-374 | Chemical | denotes | CQ | MESH:D002738 |
| 62 | 375-378 | Chemical | denotes | HCQ | MESH:D006886 |
| 70 | 89-97 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 71 | 184-192 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 72 | 299-307 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 73 | 382-390 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 105 | 557-604 | Species | denotes | severe acute respiratory syndrome coronavirus 2 | Tax:2697049 |
| 106 | 606-616 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 119 | 513-535 | Disease | denotes | Coronavirus disease-19 | MESH:C000657245 |
| 120 | 537-545 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T15 | 99-202 | Sentence | denotes | Adverse effects, including prolonged QT interval after taking CQ/HCQ, may develop in COVID-19 patients. |
| T16 | 203-494 | Sentence | denotes | Therefore, current data are not sufficient enough to support the use of CQ/HCQ as therapies for COVID-19 and increasing caution should be taken about the application of CQ/HCQ in COVID-19 before conclusive findings are obtained by well-designed, multi-center, randomized, controlled studies. |
| T17 | 496-498 | Sentence | denotes | 1. |
| T18 | 500-512 | Sentence | denotes | Introduction |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 126-147 | Phenotype | denotes | prolonged QT interval | http://purl.obolibrary.org/obo/HP_0001657 |